Peptide CRDMO Platform

Peptide CRDMO Platform
Product Description

WuXi TIDES's Peptide platform includes a complete offering of services to bring your protein therapeutic to market faster while supporting a wide variety of conjugates including PPMO, Peptide-Antibody, Peptide-Linkers.

Services include but are not limited to: - Comprehensive Discovery Service
- Process R&D
- Multi-scale peptide manufacturing (grams to kilograms) under cGMP conditions 
- Analytical characterization 
- Method development and validation 
- IPC & Release Testing 
- ICH compliant stability studies 
- Regulatory (CMC) submission support 

Read more Show less

WuXi STA

  • US
  • 2015
    On CPHI since
  • 3
    Certificates
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
View company profile
Categories
more categories Show less

WuXi STA

  • US
  • 2015
    On CPHI since
  • 3
    Certificates
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
View company profile

More Products from WuXi STA (13)

  • Oral Dose Drug Product Development & Manufacturing

    Product Oral Dose Drug Product Development & Manufacturing

    WuXI STA's comprehensive drug product development platform for oral dosage forms offers our clients a complete line of solutions from pre-formulation development through to final product manufacture at commercial scale. Our capabilities include; 

    • Solid oral tablet/capsule (including liquid...
  • F2CS - Fast to Clinical Supply Platform

    Product F2CS - "Fast to Clinical Supply" Platform

    Your innovative therapy is ready to reach a key milestone with the IND date quickly approaching. You need a reliable partner to formulate and manufacture your therapy to meet the IND filing requirements and the dose needs for phase I studies fast.

    Every innovation is unique so your partner needs...
  • F4CL - Fast for Commercial Launch Platform

    Product F4CL - "Fast for Commercial Launch" Platform

    When your CMC projects approach the final step to commercial approval, you need to consider how to be sure your drugs successfully reach your intended markets. 

    Regulatory agencies have different requirements and timing. Trust in the right partner so you don’t need to worry abou...
  • IND Enabling Preformulation Package (IEPP)

    Product IND Enabling Preformulation Package (IEPP)

    WuXi STA's IND Enabling Pre-formulation Package (IEPP) is an integrated and end-to-end developability assessment service for new chemical entities (NCE's). Through this comprehensive service, you can efficiently identify challenges and tailored solutions earlier for higher project success rates and lower o...
  • Small Molecule API Development & Manufacturing

    Product Small Molecule API Development & Manufacturing

    WuXI's unrivaled API development platform provides our client with a robust platform to bring their drug to market. With a proven track record of success and trust in bringing life changing therapeutics to market, we are a go-to partner for clients looking for tailored and customized drug development and m...
  • Bioavailability Enhancement & Advanced Delivery Technologies

    Product Bioavailability Enhancement & Advanced Delivery Technologies

    Our bioavailability toolbox offers a customizable solution to your drug delivery challenges. 

    - Spray-Dried Dispersion (SDD)
    - Hot Melt Extrusion (HME)
    - Nano-suspensions & Lipid Nanoparticles 
    - Softgel & Liquid Filled Capsules
    - Injectable Formulations\


  • Oligonucleotide CRDMO Platform

    Product Oligonucleotide CRDMO Platform

    WuXi TIDES has a robust and integrated Oligo API Platform, offering R&D and manufacturing services from preclinical to commercial scale and operating out of our US FDA inspected facility based in Changzhou, China. We support the development and manufacture of a variety of oligonucleotide modalities inc...
  • Highly Potent API (HPAPI), ADC Payload, and Payload-Linker Manufacturing

    Product Highly Potent API (HPAPI), ADC Payload, and Payload-Linker Manufacturing

    Our Jinshan and Changzhou sites are equipped with multiple R&D labs as well as a dedicated cGMP HP Kilo lab and plant for producing and manufacturing highly potent APIs (HPAPI's), antibody drug conjugates (ADC's), payloads, and payload-linkers. We currently offer drug product manufacturing at STA’...
  • Analytical Development Services

    Product Analytical Development Services

    Our comprehensive suite of analytical services help to supplement the development and manufacture of your product, ensuring high quality and consistency throughout the process.

    Services include: 
    - Analytical method development and validation  
    - API and drug product release tes...
  • in-vivo PK Studies

    Product in-vivo PK Studies

    Our drug product pre-formulation and formulation development services can also includes in vivo PK studies, conducted with multiple animal species and a rapid turnaround time. This additional service further extends our full suite offering to our clients while eliminating the need for additional vendor sou...
  • Injectable Formulation Development & Fill-Finish Services

    Product Injectable Formulation Development & Fill-Finish Services

    WuXi STA offers a wide range of tailored  services and solutions for clients developing injectable formulations. Form types include solution, emulsion, sterile powder (lyophilized) and liposome. Our offering includes formulation development, performance analysis and characterization testing, and fill/...
  • Global Regulatory Affairs & CMC Submission Support

    Product Global Regulatory Affairs & CMC Submission Support

    WuXi STA's dedicated Global Regulatory Affairs CMC teams offers comprehensive CMC documentation support for IND, CTA, MAA, and NDA applications in western countries and China. Our highly experienced team works with your NCE programs to prepare Module 2 and Module 3 of your regulatory dossier through foreca...
show all 13 other products

WuXi STA resources (2)